Products
King Pharmaceuticals has a well-recognized and highly prescribed portfolio of core-marketed products. Our leading brands include EMBEDA™ CII, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time; Avinza® CII, a once-daily morphine treatment for moderate to severe pain; Flector® Patch, a topical NSAID patch for the treatment of acute pain due to minor sprains, strains and contusions; Skelaxin®, for relief from discomfort associated with acute musculoskeletal conditions; Thrombin-JMI®, which aids in controlling bleeding during surgery; Levoxyl®, for the treatment of thyroid disorders, EpiPen®1, for the treatment of anaphylaxis; Meridian Auto-Injectors and Alpharma Animal Health.
Leading Pharmaceutical Brands
- Embeda™ CII (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules
- Avinza® CII (morphine sulfate extended release)
- Flector® Patch (diclofenac epolamine topical patch) 1.3%
- Skelaxin® (metaxalone)
- Thrombin-JMI® (thrombin, topical, bovine origin, USP)
- Levoxyl® (levothyroxine sodium tablets, USP)
Other Products
- Alphabetic Listing of Rx Pharmaceuticals
- NDC Listing of Rx Pharmaceuticals
- Alpharma Animal Health
- King Pharmaceuticals Canada
- Meridian Auto-Injectors
Information for Vermont Prescribers of Prescription Drugs
- EpiPen is a registered trademark of EMD Chemicals, Inc. under license to Dey, L.P., Napa, CA, U.S.A.
